Prediagnostic serum iodine and selenium in relation to breast cancer survival

Magdalena Szramka, Malte Sandsveden, Kamil Demircan, Signe Borgquist, Ann Rosendahl, Jonas Manjer

Open source

DOI
10.1093/bjsopen/zrag047
Published
2026-05-12
Container
BJS Open
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/bjsopen/zrag047,
  title = {Prediagnostic serum iodine and selenium in relation to breast cancer survival},
  author = {Magdalena Szramka and Malte Sandsveden and Kamil Demircan and Signe Borgquist and Ann Rosendahl and Jonas Manjer},
  year = {2026},
  journal = {BJS Open},
  doi = {10.1093/bjsopen/zrag047},
  url = {https://doi.org/10.1093/bjsopen/zrag047}
}

RIS

TY  - JOUR
TI  - Prediagnostic serum iodine and selenium in relation to breast cancer survival
AU  - Magdalena Szramka
AU  - Malte Sandsveden
AU  - Kamil Demircan
AU  - Signe Borgquist
AU  - Ann Rosendahl
AU  - Jonas Manjer
PY  - 2026
JO  - BJS Open
DO  - 10.1093/bjsopen/zrag047
UR  - https://doi.org/10.1093/bjsopen/zrag047
ER  - 

APA

Szramka, M., Sandsveden, M., Demircan, K., Borgquist, S., Rosendahl, A., & Manjer, J. (2026). Prediagnostic serum iodine and selenium in relation to breast cancer survival. BJS Open. https://doi.org/10.1093/bjsopen/zrag047

Source records